Sanofi (Pharmaceutical and healthcare)

This Company Profile from Euromonitor provides key details and analysis of Sanofi, the French pharmaceutical company, in the worldwide consumer health market.
  • In 2022, Sanofi saw strong growth in sales of analgesics as consumers sought to self-treat mild cases of COVID-19, flus and colds.
  • The company has been strategically divesting non-core brands, and the upcoming spin-off of its consumer health business aims to build brand equity and unlock growth.
  • With the US remaining Sanofi’s largest market, the company is looking to boost its low APAC market share by bringing in digitalisation expertise from the beauty industry and developing its local partnerships....

Not a subscriber?

Schedule your live demo with our team today

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

We’re long-term subscribers to WARC and it’s a tool we use extensively. We use it to source case studies and best practice for the purposes of internal training, as well as for putting persuasive cases to clients. In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with numerous case studies sourced from WARC. It helped bring what could have been a relatively dry deck to life with recognisable brand successes from across a broad number of categories. It’s incredibly efficient to have such a wealth of insight in one place.

Insights Team
Bray Leino

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands